Geoffrey M. Parker
CHIEF FINANCIAL OFFICER; Director · 3 filings · Latest: May 13, 2026
Allogene Therapeutics, Inc.
PERRIGO Co plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PRGO | Geoffrey M. Parker | Director | May 14, 2026 | Option Exercise | $10.84 | 7,305 | $79.2K | 36,217 | |
ALLO | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Feb 2, 2026 | Sale | $1.76 | 24,001 | $42.2K | 1,252,795 | |
ALLO | GEOFFREY M PARKER | — | Feb 2, 2026 | Proposed Sale | $1.76 | 24,001 | $42.2K | — | |
ALLO | Parker Geoffrey M. | — | Oct 21, 2025 | Proposed Sale | $1.26 | 36,744 | $46.2K | — | |
ALLO | Parker Geoffrey M. | — | Feb 3, 2025 | Proposed Sale | $1.73 | 4,361 | $7.5K | — | |
ALLO | Parker Geoffrey M. | — | Oct 21, 2024 | Proposed Sale | $2.84 | 36,404 | $103.5K | — |